HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Clodronate

HCID 25419
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
10596-23-3
Standard SMILES
O=P(O)(O)C(Cl)(Cl)P(=O)(O)O
InChIKey
ACSIXWWBWUQEHA-UHFFFAOYSA-N
Molecular formula
CH4Cl2O6P2
Average molar mass
244.89 g/mol
Monoisotopic mass
243.8860172

Overview

Clodronic acid is an organochlorine compound that is methylene chloride in which both hydrogens are replaced by phosphonic acid groups. It inhibits bone resorption and soft tissue calcification, and is used (often as the disodium salt tetrahydrate) as an adjunct in the treatment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions and bone pain associated with skeletal metastases. It has a role as an antineoplastic agent and a bone density conservation agent. It is an organochlorine compound, a one-carbon compound and a 1,1-bis(phosphonic acid). It is a conjugate acid of a clondronate(2-).

Names & identifiers

Preferred name
Clodronate
IUPAC
[dichloro(phosphono)methyl]phosphonic acid
English name
Clodronic acid
Molecular formula
CH4Cl2O6P2
Molecular weight
244.89

Names & synonyms

Clodronic Acid10596-23-3Clodronate(Dichloromethylene)diphosphonic acidAcido clodronicoAcide clodroniqueAcidum clodronicumClodronsaeure[dichloro(phosphono)methyl]phosphonic acidDichloromethylidene diphosphonate(Dichloromethylene)bisphosphonic acidDichloromethanediphosphonic acid
Show more names
diphosphonic acidClodronicDichloromethylenebisphosphonic acid(Dichloromethylene)bis(phosphonic acid)ARC-69931Aids071014Aids-071014Clodronate AcidClodronic acid 18O3
Phosphonic acid, (dichloromethylene)bis-ClasteonLoron(Dichloro-phosphono-methyl)-phosphonic aciddichloromethylene-1,1-diphosphonic aciddichloromethylene-1,1-bisphosphonic acidDTXSID8046959Acid, Clodronic

Database identifiers

CAS
10596-23-3

Properties

Computed structural properties

XLogP
-2.1
Topological polar surface area
115 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
6
Rotatable bonds
2
Heavy atoms
11
Formal charge
0
Complexity
211

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals

Pharmaceuticals -> Listed in ZINC15

LogP-2.4
Solubility7.47e+00 g/L
Animal Drugs · 2 items

FDA approved animal drugs -> Active ingredient

Pharmaceuticals -> UK Veterinary Medicines Directorate List

Melting Point250 °C
Physical DescriptionSolid

Physicochemical properties

Melting point
249 · 249-251°
Boiling point
474.7 · 474.7±55.0 °C(Predicted)
Density
2.306 · 2.306±0.06 g/cm3(Predicted)
storage temp.
2 · under inert gas (nitrogen or Argon) at 2-8°C
form
Solid

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Health EffectsDecreases in serum calcium following substantial overdosage may be expected in some patients.
Exposure RoutesOral, Intravenous. After oral administration, absorption is estimated at 1–3% of the ingested dose because of the low uptake from the gastrointestinal tract.
Toxicity Summary · 1 item

The bisphosphonate group binds strongly to the bone mineral, hydroxyapatite. This explains the specific pharmacological action of these compounds on mineralized tissues, especially bone. The exact mechanism of action of clodronate is not known, however it is known that it does not inhibit protein isoprenylation but can be metabolized intracellularly to a &beta;-&gamma;-methylene (AppCp-type) analog of ATP (AppCCl2p), which is cytotoxic to macrophages in vitro. Inhibition of the ADP/ATP translocase by the metabolite AppCCl2p is a likely route by which clodronate causes osteoclast apoptosis and inhibits bone resorption. Recently, the slime mold <i>Dictyostelium discoideum</i> was shown to take up bisphosphonates by pinocytosis. In these cells, clodronate, but not other pharmacologically active bisphosphonates, was incorporated into adenine nucleotides, which could potentially explain why this bisphosphonate sometimes seems to act differently than the other bisphosphonates. Clodronate, like all biphosphonates, also binds protein-tyrosine-phosphatase.

Signs and SymptomsSigns and symptoms of hypocalcemia also may occur in some of these patients.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 4 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Clodronic acid

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Safety data

Chemistry & industry

Pharmacology

ATC Code · 3 items

M05BA02

M - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingClodronic acid is 36% protein bound in plasma.
Pharmacodynamics · 1 item

Clodronic acid is a first generation bisphosphonate that inhibits osteoclast mediated bone resorption. It has a wide therapeutic index as a large overdose is required for significant toxicity and a long duration of action due to the slow release from bone. Patients should be counselled regarding the risk of hypocalcemia, hypovolemia, renal insufficiency, transient hyperphosphatemia, and transient hyperparathyroidism.

Mechanism of Action · 1 item

Bisphosphonates are taken into the bone where they bind to hydroxyapatite. Bone resorption by osteoclasts causes local acidification, releasing the bisphosphonate, which is taken into the osteoclast by fluid-phase endocytosis. Endocytic vesicles become acidified, releasing bisphosphonates into the cytosol of osteoclasts where they act. Osteoclasts mediate resorption of bone. When osteoclasts bind to bone they form podosomes, ring structures of F-actin. Disruption of the podosomes causes osteoclasts to detach from bones, preventing bone resorption. First generation bisphosphonates closely mimic the structure of pyrophosphate, which can be incorporated into ATP anologues that cannot be hydrolyzed, disrupting all ATP mediated actions of osteoclasts.

Biological Half-LifeThe mean plasma half life of clodronate is 5.6h.
Metabolism/Metabolites · 2 items

Clodronate is not metabolized in humans.

Clodronate is not metabolized in humans. It can be metabolized intracellularly to a beta-gamma-methylene (AppCp-type) analog of ATP (AppCCl2p), which is cytotoxic to macrophages in vitro. Half Life: Approximately 13 hours.

MeSH Pharmacological ClassificationAgents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

Related reactions

7 records
New reaction record
HRID 431286 reaction equation
HRID 431286As reactant
HRID 1157346 reaction equation
HRID 1157346As product
HRID 1181911 reaction equation
HRID 1181911As product
HRID 1182403 reaction equation
HRID 1182403As reactant
HRID 1602952 reaction equation
HRID 1602952As reactant
HRID 1602975 reaction equation
HRID 1602975As reactant
HRID 1817514 reaction equation
HRID 1817514As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
25419
DTXSID
DTXSID8046959
ChEMBL
CHEMBL12318
ChEBI
CHEBI:110423
UNII
0813BZ6866
EC Number
234-212-1
Nikkaji
J10.448E
pka
0.75 · 0.75±0.10(Predicted)
color
Off-white to light yellow
InChI
InChI=1S/CH4Cl2O6P2/c2-1(3,10(4,5)6)11(7,8)9/h(H2,4,5,6)(H2,7,8,9)
InChIKey
ACSIXWWBWUQEHA-UHFFFAOYSA-N
SMILES
C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl
EWG's Food Scores
1 · 1
FDA UNII
813 BZ6866 · 0813BZ6866
ATC code
5 BA02 · M05BA02
Symbol(GHS)
5 · GHS05
Signal word
Danger
Hazard statements
314 · H314-H290
Precautionary statements
501 · P501-P260-P234-P264-P280-P390-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P406-P405
Signal word
Danger
Symbol(GHS)
GHS05
Hazard statements
H314-H290
Precautionary statements
P501-P260-P234-P264-P280-P390-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P406-P405
Absorption, Distribution and Excretion · 3 items

Oral clodronic acid has a bioavailability of 1-2%. A 200mg intravenous dose reaches a Cmax of 16.1mg/L with an AUC of 44.2mg\*h/L. A 200mg intramuscular dose reaches a Cmax of 12.8mg/L with an AUC of 47.5mg\*h/L. Further pharmacokinetic data for clodronic acid are not readily available.

Clodronate is eliminated unchanged in the urine.

The renal clearance of clodronate is approximately 90mL/min.

Cellular LocationsCytoplasm

Uses & manufacturing

Uses · 2 items

Use (kg; approx.) in Germany (2009): >500

A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification. For the management of hypercalcemia of malignancy and as an adjunct in the management of osteolysis resulting from bone metastases of malignant tumors.

Applications

UsesRegulator (calcium).

UsesClodronic Acid is a bisphosphonate that can be used in the treatment of osteoporosis. Its ATP-analogs can inhibit cell signaling pathways.

Upstream & downstream products

Upstream raw materials

Dibromomethane
Additional notes · 1 item

DefinitionChEBI: An organochlorine compound that is methylene chloride in which both hydrogens are replaced by phosphonic acid groups. It inhibits bone resorption and soft tissue calcification, and is used (often as the disodium salt tetrahydrate) as an adjunct in the trea ment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions and bone pain associated with skeletal metastases.